ModAstera es una plataforma de desarrollo de IA sin código diseñada para aplicaciones médicas. Automatiza el modelado predictivo para el riesgo y los resultados de los pacientes, con anotación de datos asistida por IA y despliegue con un solo clic para reducir significativamente el tiempo y los costos de desarrollo para los innovadores de health tech.
Tempus es una empresa tecnológica líder que impulsa la medicina de precisión mediante la aplicación práctica de la inteligencia artificial en la atención sanitaria. Utiliza una de las bibliotecas de datos clínicos y moleculares multimodales más grandes del mundo para ayudar a los médicos a ofrecer una atención personalizada al paciente y acelerar el descubrimiento y desarrollo de nuevas terapias.
ModAstera es una plataforma de desarrollo de IA sin código diseñada para aplicaciones médicas. Automatiza el modelado predictivo para el riesgo y los resultados de los pacientes, con anotación de datos asistida por IA y despliegue con un solo clic para reducir significativamente el tiempo y los costos de desarrollo para los innovadores de health tech.
Tempus es una empresa tecnológica líder que impulsa la medicina de precisión mediante la aplicación práctica de la inteligencia artificial en la atención sanitaria. Utiliza una de las bibliotecas de datos clínicos y moleculares multimodales más grandes del mundo para ayudar a los médicos a ofrecer una atención personalizada al paciente y acelerar el descubrimiento y desarrollo de nuevas terapias.
| Feature | ModAstera | Tempus |
|---|---|---|
| Categoría principal | Aprendizaje Automático | Soporte Clínico |
| Añadido | 2025-10-22 | 2025-09-19 |
| Precio | Freemium | Sin verificar |
| Sitio oficial | www.modastera.com | tempus.com |
| Tipo de producto | Sitio web | Sitio web |
| Performance data | ||
| Valoración | Sin verificar | Sin verificar |
| Comentarios | 0 | 0 |
| Visitas mensuales | 250 | 151.5K |
| Crecimiento mensual | -68.4% | 15.9% |
| Favoritos | 85 | 121 |
| Details | Ver detalles | Ver detalles |
Compare ModAstera and Tempus by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
In the ModAstera vs Tempus monthly traffic comparison, ModAstera currently shows 250 visits and Tempus shows 151.5K; Tempus has about 605.8 times the visible traffic of ModAstera, an absolute difference of about 151.2K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 86.21% | 130.6K |
| 🇮🇳India | 4.87% | 7.4K |
| 🇰🇷Korea, Republic of | 4.08% | 6.2K |
| 🇨🇦Canada | 2.71% | 4.1K |
| 🇳🇬Nigeria | 2.13% | 3.2K |
| Source type | Percentage | Traffic |
|---|---|---|
| Referido | 48.63% | 73.7K |
| Directo | 47.07% | 71.3K |
| Correo electrónico | 4.3% | 6.5K |
This in-depth ModAstera vs Tempus comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. ModAstera is primarily listed under “Aprendizaje Automático”, while Tempus is primarily listed under “Soporte Clínico”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (ModAstera: Aprendizaje Automático; Tempus: Soporte Clínico); Pricing (ModAstera: Freemium; Tempus: Not disclosed); Monthly visits (ModAstera: 250; Tempus: 151.5K); Monthly growth (ModAstera: -68.4%; Tempus: 15.9%); Favorites (ModAstera: 85; Tempus: 121). These facts are more useful for selection than brand visibility alone.
In the ModAstera vs Tempus monthly traffic comparison, ModAstera currently shows 250 visits and Tempus shows 151.5K; Tempus has about 605.8 times the visible traffic of ModAstera, an absolute difference of about 151.2K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
If public market visibility is an important first-pass criterion, investigate Tempus first. The final choice should still follow taxonomy, use case, and a real trial because higher traffic does not prove broader capabilities or better workflow fit.
ModAstera and Tempus currently overlap in shared roles: Bioinformático, Científico de Datos e Investigador Médico. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
ModAstera's unique categories/tags are Aprendizaje Automático, Plataforma No-Code, IA Médica, Desarrollo de IA, investigación clínica, anotación de datos, IA en salud y Tecnología de la salud; Tempus's are Soporte Clínico, Investigación Médica, Medicina de Precisión, IA en la atención médica, Asistente Clínico, Ensayos clínicos, Descubrimiento de fármacos e Integración de HCE. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
ModAstera has no verified rating, 0 comments, 85 favorites, and 88 likes；Tempus has no verified rating, 0 comments, 121 favorites, and 118 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Put ModAstera on the priority trial list when the task aligns with “Aprendizaje Automático” and especially Aprendizaje Automático, Plataforma No-Code, IA Médica, Desarrollo de IA, investigación clínica y anotación de datos, or the users include Clínico, Gerente de TI de Salud, Emprendedor de tecnología de la salud e Ingeniero de Machine Learning. This follows recorded positioning and does not imply unlisted capabilities are absent.
ModAstera also currently records: pricing is freemium, product type is website, 250 verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
Put Tempus on the priority trial list when the task aligns with “Soporte Clínico” and especially Soporte Clínico, Investigación Médica, Medicina de Precisión, IA en la atención médica, Asistente Clínico y Ensayos clínicos, or the users include Gerente de Ensayos Clínicos, Administrador de Atención Médica, Oncólogo y Científico Farmacéutico. This follows recorded positioning and does not imply unlisted capabilities are absent.
Tempus also currently records: pricing is not verified, product type is website, 151.5K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in ModAstera and Tempus, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.
